Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −421 $326.81 $138K 26,053
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −353 $327.67 $116K 25,700
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −107 $328.71 $35K 25,593
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −182 $329.71 $60K 25,411
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −87 $330.85 $29K 25,324
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −101 $331.93 $34K 25,223
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −42 $332.64 $14K 25,181
2026-03-02 Garg Pushkal EVP Chief R&D Grant or award · Stock Option (right to buy) 10b5-1 +10,480 10,480
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award 10b5-1 +3,688 25,110
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −47 $323.62 $15K 25,063
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −90 $324.65 $29K 24,973
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −258 $325.63 $84K 24,715
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −392 $326.81 $128K 24,323
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −329 $327.67 $108K 23,994
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −100 $328.71 $33K 23,894
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −170 $329.71 $56K 23,724
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −81 $330.85 $27K 23,643
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −94 $331.93 $31K 23,549
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −37 $332.64 $12K 23,512
2026-03-02 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award · Stock Option (right to buy) 10b5-1 +8,105 8,105

Page 7 of 41 · 816 trades